A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition
Harrigan, Edmund P, Miceli, Jeffrey J, Anziano, Richard, Watsky, Eric, Reeves, Karen R, Cutler, Neal R, Sramek, John, Shiovitz, Thomas, Middle, Michelle
Published in Journal of clinical psychopharmacology (01.02.2004)
Published in Journal of clinical psychopharmacology (01.02.2004)
Get more information
Journal Article
Varenicline, an alpha 4 beta 2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation: A Randomized Controlled Trial
Gonzales, David, Rennard, Stephen I, Nides, Mitchell, Oncken, Cheryl, Azoulay, Salomon, Billing, Clare B, Watsky, Eric J, Gong, Jason, Williams, Kathryn E, Reeves, Karen R
Published in JAMA : the journal of the American Medical Association (05.07.2006)
Published in JAMA : the journal of the American Medical Association (05.07.2006)
Get full text
Journal Article
Effect of Maintenance Therapy With Varenicline on Smoking Cessation: A Randomized Controlled Trial
Tonstad, Serena, Tønnesen, Philip, Hajek, Peter, Williams, Kathryn E, Billing, Clare B, Reeves, Karen R, Varenicline Phase 3 Study Group, for the
Published in JAMA : the journal of the American Medical Association (05.07.2006)
Published in JAMA : the journal of the American Medical Association (05.07.2006)
Get full text
Journal Article
Efficacy of Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation: A Randomized Controlled Trial
Jorenby, Douglas E, Hays, J. Taylor, Rigotti, Nancy A, Azoulay, Salomon, Watsky, Eric J, Williams, Kathryn E, Billing, Clare B, Gong, Jason, Reeves, Karen R, Varenicline Phase 3 Study Group, for the
Published in JAMA : the journal of the American Medical Association (05.07.2006)
Published in JAMA : the journal of the American Medical Association (05.07.2006)
Get full text
Journal Article
Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation: A Randomized Controlled Trial
Gonzales, David, Rennard, Stephen I, Nides, Mitchell, Oncken, Cheryl, Azoulay, Salomon, Billing, Clare B, Watsky, Eric J, Gong, Jason, Williams, Kathryn E, Reeves, Karen R, Varenicline Phase 3 Study Group, for the
Published in JAMA : the journal of the American Medical Association (05.07.2006)
Published in JAMA : the journal of the American Medical Association (05.07.2006)
Get full text
Journal Article
Efficacy of Varenicline, an alpha 4 beta 2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation: A Randomized Controlled Trial
Jorenby, Douglas E, Hays, JTaylor, Rigotti, Nancy A, Azoulay, Salomon, Watsky, Eric J, Williams, Kathryn E, Billing, Clare B, Gong, Jason, Reeves, Karen R
Published in JAMA : the journal of the American Medical Association (05.07.2006)
Published in JAMA : the journal of the American Medical Association (05.07.2006)
Get full text
Journal Article
Efficacy and tolerability of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in japanese smokers
NAKAMURA, Masakazu, OSHIMA, Akira, FUJIMOTO, Yoko, MARUYAMA, Nami, ISHIBASHI, Taro, REEVES, Karen R
Published in Clinical therapeutics (01.06.2007)
Published in Clinical therapeutics (01.06.2007)
Get full text
Journal Article
The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial
Niaura, Raymond, Hays, J. Taylor, Jorenby, Douglas E., Leone, Frank T., Pappas, John E., Reeves, Karen R., Williams, Kathryn E., Billing, Clare B.
Published in Current medical research and opinion (01.07.2008)
Published in Current medical research and opinion (01.07.2008)
Get full text
Journal Article
Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial
DANIEL, David G, POTKIN, Steven G, REEVES, Karen R, SWIFT, Rachel H, HARRIGAN, Edmund P
Published in Psychopharmacologia (01.05.2001)
Published in Psychopharmacologia (01.05.2001)
Get full text
Journal Article
Comment: Oral varenicline for smoking cessation
Gonzales, David, Rennard, Stephen I, Jorenby, Douglas E, Reeves, Karen R
Published in The Annals of pharmacotherapy (01.04.2007)
Published in The Annals of pharmacotherapy (01.04.2007)
Get more information
Journal Article
Ziprasidone 80 mg/day and 160 mg/day in the Acute Exacerbation of Schizophrenia and Schizoaffective Disorder: A 6-Week Placebo-Controlled Trial
Daniel, David G, Zimbroff, Dan L, Potkin, Steven G, Reeves, Karen R, Harrigan, Edmund P, Lakshminarayanan, Mani
Published in Neuropsychopharmacology (New York, N.Y.) (01.05.1999)
Published in Neuropsychopharmacology (New York, N.Y.) (01.05.1999)
Get full text
Journal Article
Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers
Nakamura, Masakazu, Oshima, Akira, Fujimoto, Yoko, Maruyama, Nami, Ishibashi, Taro, Reeves, Karen R
Published in Clinical therapeutics (01.06.2007)
Get full text
Published in Clinical therapeutics (01.06.2007)
Journal Article
Efficacy and tolerability of varenicline, an [alpha]4[beta]2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers
Nakamura, Masakazu, Oshima, Akira, Fujimoto, Yoko, Maruyama, Nami, Ishibashi, Taro, Reeves, Karen R
Published in Clinical therapeutics (01.06.2007)
Published in Clinical therapeutics (01.06.2007)
Get full text
Journal Article
Efficacy and tolerability of varenicline, an α 4β 2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers
Nakamura, Masakazu, Oshima, Akira, Fujimoto, Yoko, Maruyama, Nami, Ishibashi, Taro, Reeves, Karen R.
Published in Clinical therapeutics (2007)
Published in Clinical therapeutics (2007)
Get full text
Journal Article
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial
Gonzales, David, Rennard, Stephen I, Nides, Mitchell, Oncken, Cheryl, Azoulay, Salomon, Billing, Clare B, Watsky, Eric J, Gong, Jason, Williams, Kathryn E, Reeves, Karen R
Published in JAMA : the journal of the American Medical Association (05.07.2006)
Get full text
Published in JAMA : the journal of the American Medical Association (05.07.2006)
Journal Article
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial
Jorenby, Douglas E, Hays, J Taylor, Rigotti, Nancy A, Azoulay, Salomon, Watsky, Eric J, Williams, Kathryn E, Billing, Clare B, Gong, Jason, Reeves, Karen R
Published in JAMA : the journal of the American Medical Association (05.07.2006)
Get full text
Published in JAMA : the journal of the American Medical Association (05.07.2006)
Journal Article
Efficacy and tolerability of varenicline, an α4 β2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers
Nakamura, Masakazu, MD, Oshima, Akira, MD, Fujimoto, Yoko, MD, PhD, Maruyama, Nami, MSc, Ishibashi, Taro, MSc, Reeves, Karen R., MD
Published in Clinical therapeutics (2007)
Published in Clinical therapeutics (2007)
Get full text
Journal Article